Zenlabs Ethica Limited Submits Q4FY26 Compliance Certificate Under SEBI Regulations

Zenlabs Ethica Limited has fulfilled its regulatory compliance obligations by submitting the mandatory quarterly certificate under SEBI regulations for the quarter ended March 31, 2026. The pharmaceutical company filed the required documentation with BSE Limited on April 10, 2026.

Regulatory Compliance Details

The compliance certificate was issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This regulation requires companies to submit quarterly certificates regarding dematerialisation activities through their designated Registrar and Share Transfer Agents.

Parameter:	Details
Certificate Date:	April 6, 2026
Quarter Covered:	January 1, 2026 to March 31, 2026
Issuing Authority:	Bigshare Services Private Limited
Submission Date:	April 10, 2026

Certificate Confirmation

Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent, confirmed that no dematerialisation requests for equity shares were received during the specified quarter. The certificate was signed by Akash Shamal, Authorised Signatory of Bigshare Services Private Limited.

The confirmation covers the complete period from January 1, 2026 to March 31, 2026, indicating no activity in terms of share dematerialisation requests during this timeframe.

Company Submission

The certificate was formally submitted to BSE Limited by Sanjay Dhir, Whole-time Director of Zenlabs Ethica Limited. The submission was made to the Corporate Relationship Department of BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai.

Company Details:	Information
CIN Number:	L74900CH1993PLC033112
Registered Office:	Plot No. 194-195, 3rd Floor, Industrial Area, Phase-II, Chandigarh
Director:	Sanjay Dhir (DIN: 02452461)
RTA:	Bigshare Services Private Limited

This quarterly compliance filing demonstrates the company's adherence to SEBI regulatory requirements and maintains transparency in its share transfer and dematerialisation processes.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.06%	+2.20%	+27.72%	-27.93%	-26.31%	-4.63%

Zenlabs ethica Ltd has submitted a regulatory declaration confirming that no encumbrance was created on promoter equity shares during the financial year ended March 31, 2026. The declaration was filed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

Regulatory Compliance Declaration

Sanjay Dhir, promoter of Zenlabs Ethica Limited, submitted the declaration on April 6, 2026, on behalf of all promoters, promoter group members, and persons acting in concert. The filing confirms that no direct or indirect encumbrance was made on equity shares held by the promoter group during FY26.

Parameter	Details
Declaration Date	April 6, 2026
Financial Year Covered	Ended March 31, 2026
Encumbered Shares	NIL
Pledged Shares	NIL
Regulatory Framework	SEBI SAST Regulations 2011

Promoter Group Structure

The company's promoter and promoter group structure includes seven entities across different categories. The promoter category comprises three members, while the promoter group consists of four individuals.

Category	Members
Promoters	Sanjay Dhir, Sanjeev Kumar, Preet Remedies Ltd.
Promoter Group	Himjyoti, Harjinder Kaur, Kulwant Kaur, Daman Singhal

Corporate Information

Zenlabs Ethica Limited operates from its registered office located at Plot No. 194-195, 3rd Floor, Industrial Area, Phase-II, Chandigarh. The company maintains regular compliance with stock exchange requirements and regulatory frameworks governing substantial shareholding disclosures.

The declaration reinforces the company's commitment to maintaining transparent shareholding practices and adherence to SEBI regulations regarding promoter shareholding patterns and encumbrance disclosures.